Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)-

Request For Quotation
Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)- Suppliers list
Company Name: Daicel Chiral Technologies (China)CO.,LTD  
Tel: 021-50460086-9 15921403865
Email: han_yajun@dctc.daicel.com
Company Name: Shanghai Anyinuo Biomedical Technology Co., Ltd.  
Tel: 021-34625901
Email: 420970979@qq.com
Company Name: Yangzhou modier Electronic Materials Co., Ltd  
Tel: 13761402923 19975033992
Email: market@modeltemol.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-1647117 13681763483
Email: product02@bidepharm.com
Company Name: Nantong Hanfang Biotechnology Co. , Ltd.  
Tel: hanfangpharma@126.com 18017580634
Email: hanfangpharma@126.com
Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)- Basic information
Product Name:Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)-
Synonyms:(11aR)-1,10-Bis(3,5-di-tert-butylphenyl)-12-hydroxy-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide;(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin;Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)-
CAS:1639448-07-9
MF:C45H55O4P
MW:690.89
EINECS:
Product Categories:
Mol File:1639448-07-9.mol
Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)- Structure
Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)- Chemical Properties
Boiling point 734.4±70.0 °C(Predicted)
density 1.18±0.1 g/cm3(Predicted)
pka1.15±0.20(Predicted)
Safety Information
MSDS Information
Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)- Usage And Synthesis
Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)- Preparation Products And Raw materials
Tag:Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aR)-(1639448-07-9) Related Product Information
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tris(1-methylethyl)phenyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide (11aS)-3,7-Bis[2,4,6-tris(1-methylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide Diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aS)- (11aR)-5-oxide-3,7-bis(3,5-diMethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin (11aS)-5-oxide-3,7-bis(3,5-diMethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin